Modified Release Minoxidil for Hair Loss Treatment
Summary
The USPTO published patent application US20260091034A1 by inventor Reid Waldman for a modified release oral formulation of minoxidil for treating hair loss. The application discloses pharmaceutical compositions including daily doses of modified release minoxidil, potentially combined with additional active agents, delivered via a slow release vehicle. The filing date is December 4, 2025, with publication on April 2, 2026.
What changed
USPTO published patent application US20260091034A1 titled 'Compositions and Methods of Use for Modified Release Minoxidil' filed by inventor Reid Waldman. The application covers pharmaceutical formulations for oral administration comprising daily doses of modified release minoxidil or salts thereof, methods of treating hair loss, and kits containing slow modified release vehicles with oral minoxidil. CPC classifications indicate compositions for anti-alopecia applications using controlled release technologies (A61K 9/0053, A61K 9/2013, A61K 9/2054).
Patent applications do not create immediate compliance obligations for third parties. Pharmaceutical companies developing minoxidil-based hair loss products should review the application claims to assess potential IP conflicts or licensing considerations. The application remains pending examination and may be amended during prosecution. Inventors or companies with similar technologies should monitor the prosecution history for potential prior art implications.
Archived snapshot
Apr 3, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
Application US20260091034A1 Kind: A1 Apr 02, 2026
Inventors
Reid WALDMAN
Abstract
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.
CPC Classifications
A61K 31/506 A61K 9/0053 A61K 9/2013 A61K 9/2018 A61K 9/2054 A61K 9/28 A61P 17/14
Filing Date
2025-12-04
Application No.
19409546
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.